PATENT CLAIM ANALYSIS

Application Number: 16173114
Application Type: Utility
Filing Date: 2018-10
Publication Date: 2019-02
Patent Classification: ["424", "136100"]

Abstract:
Multispecific proteins that bind and specifically redirect NK cells to lyse a target cell of interest are provided without non-specific activation of NK cells in absence of target cells. The proteins have utility in the treatment of disease, notably cancer or infectious disease.

Claim (Index 91):
The multispecific antigen binding protein of  claim 79 , wherein the therapeutic antigen-binding ABD is a Fab comprised of a V H  domain and a V L  domain, wherein each of the V H  and V L  domains is fused to a human C H1  or C \u03ba  constant domain.

Metadata:
- Claim Count in Document: 59.0
- Percentile: 97.0
- Lexical Diversity: 1.31429
- Patent Class: 424.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15190337', '15321650', '14691509', '16041309', '11921123']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7700898505450231
- 35 USC 102 Novelty (BERT): 0.7163288719671643
- Combined Prediction Score: 0.7647137526872373
- Mean Citation Score: 535.968584
- Max Citation Score: 918.7742
- Similarity Product: 746.0706962206958

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test